Published in Dermatologica on January 01, 1977
Rapid identification of monocytes in a mixed mononuclear cell preparation. J Immunol Methods (1977) 4.12
Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol (2000) 2.68
Basement zone antibodies in bullous pemphigoid. JAMA (1967) 2.66
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest (1976) 2.19
The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol (1968) 2.17
4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2. J Med Chem (2000) 1.84
Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med (1969) 1.83
Melkersson-Rosenthal syndrome: a review of 36 patients. J Am Acad Dermatol (1989) 1.77
Urban legends: recurrent aphthous stomatitis. Oral Dis (2011) 1.68
Cicatricial pemphigoid. J Am Acad Dermatol (1991) 1.66
Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis. Mayo Clin Proc (1978) 1.62
Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis. J Am Acad Dermatol (1998) 1.41
Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol (1971) 1.39
Oral ulcerations are associated with the loss of response to infliximab in Crohn's disease. J Oral Pathol Med (2005) 1.38
Immunofluorescence of cutaneous vasculitis associated with systemic disease. Arch Dermatol (1971) 1.38
The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest (1976) 1.33
Circulating immune complexes in active Behçet's disease. Clin Exp Immunol (1978) 1.32
Lymphocytotoxicity in recurrent aphthous stomatitis. Lymphocytotoxicity for oral epithelial cells in recurrent aphthous stomatitis and Bechet syndrome. Arch Dermatol (1974) 1.30
Becker's nevus: an androgen-mediated hyperplasia with increased androgen receptors. J Am Acad Dermatol (1984) 1.28
Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Arch Dermatol (1982) 1.26
The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. J Lab Clin Med (1975) 1.24
The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids. J Clin Invest (1973) 1.20
Metal transporters that contribute copper to metallochaperones in Saccharomyces cerevisiae. Mol Genet Genomics (2001) 1.18
Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b. Immunology (1978) 1.18
Bullous and cicatricial pemphigoid. Clinical, histopathologic, and immunopathologic correlations. Mayo Clin Proc (1977) 1.17
The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation. Clin Immunol Immunopathol (1975) 1.17
Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br J Dermatol (1971) 1.15
Negative complement immunofluorescence in pemphigus. J Invest Dermatol (1971) 1.15
T and B lymphocytes in contact and atopic dermatitis. Arch Dermatol (1976) 1.15
Oral pemphigus vulgaris. A report of ten cases. Arch Dermatol (1977) 1.14
Orofacial manifestations of Melkersson-Rosenthal syndrome. A study of 42 patients and review of 220 cases from the literature. Oral Surg Oral Med Oral Pathol (1992) 1.11
Classical and alternate pathway activation of complement in pemphigus vulgaris lesions. J Invest Dermatol (1974) 1.11
The treatment of desquamative gingival lesions. J Periodontol (1987) 1.10
Cutaneous vascular immunofluorescence in rheumatoid arthritis. Correlation with circulating immune complexes and vasculitis. Am J Med (1980) 1.09
Childhood bullous dermatitis herpetiformis. Negative immunofluorescent tests. Arch Dermatol (1970) 1.07
Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients. Ann Rheum Dis (1976) 1.07
Comparison of three immunoassays for immune complexes in rheumatoid arthritis. Arthritis Rheum (1979) 1.04
Erythema multiforme: direct immunofluorescence studies and detection of circulating immune complexes. J Invest Dermatol (1980) 1.03
Lupus erythematosus profundus with periorbital swelling and proptosis. J Am Acad Dermatol (1991) 1.02
American Urological Association symptom index in the assessment of urethroplasty outcomes. J Urol (1998) 1.02
Melkersson-Rosenthal syndrome. Semin Dermatol (1995) 1.01
Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol (1982) 1.01
Relevant contact sensitivities in patients with the diagnosis of oral lichen planus. J Am Acad Dermatol (2000) 1.00
Erythema nodosum-like lesions in Behçet's syndrome: a histopathologic study of 30 cases. J Cutan Pathol (1989) 1.00
Pemphigus antibodies: their role in disease. J Invest Dermatol (1971) 1.00
Herpes gestationis. New immunologic findings. Arch Dermatol (1974) 0.99
Immunopathologic mechanisms in pemphigus and bullous pemphigoid. J Invest Dermatol (1985) 0.99
Barium studies in esophageal cicatricial pemphigoid. Abdom Imaging (1995) 0.99
Hyperglucagonaemia and necrolytic migratory erythema in cirrhosis--possible pseudoglucagonoma syndrome. Br J Dermatol (1979) 0.98
Complement activation in bullous skin diseases. J Invest Dermatol (1975) 0.98
Bullous pemphigoid antigen: isolation from normal human skin. J Immunol (1977) 0.98
Geriatric herpes zoster. J Am Geriatr Soc (1971) 0.97
Inflammation in acne vulgaris: leukocyte attraction and cytotoxicity by comedonal material. J Invest Dermatol (1980) 0.96
Complement activation in pemphigus and bullous pemphigoid. J Invest Dermatol (1976) 0.96
C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay. Clin Exp Immunol (1977) 0.96
Woolly hair nevus. J Am Acad Dermatol (1990) 0.96
Antinuclear antibodies: their significance in scleroderma. Mayo Clin Proc (1971) 0.95
Vasculitis in chronic urticaria: an immunopathologic study. J Invest Dermatol (1981) 0.95
Diffuse normolipaemic plane xanthomatosis. An abnormal complement component profile. Clin Exp Immunol (1974) 0.94
Diagnosis and treatment of mycetoma. J Am Acad Dermatol (1982) 0.94
Complement fixation by pemphigus antibody. II. Complement enhanced detachment of epidermal cells. Clin Exp Immunol (1985) 0.93
Deposition of the membrane attack complex of complement in pemphigus vulgaris and pemphigus foliaceus skin. J Invest Dermatol (1989) 0.93
Subclass distribution of human IgG autoantibodies in pemphigus. J Clin Immunol (1988) 0.93
Papulonecrotic tuberculid secondary to Mycobacterium bovis. Arch Dermatol (1978) 0.92
Direct immunofluorescence in the diagnosis of scleroderma syndromes. Br J Dermatol (1977) 0.91
Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria. Cutis (1994) 0.91
Treatment of actinomycetoma with dapsone. A report of infection with Nocardia asteroides. Arch Dermatol (1974) 0.91
Evaluation of the effectiveness of griseofulvin, tolnaftate, and placebo in the topical therapy of superficial dermatophytoses. J Invest Dermatol (1975) 0.90
The sensitivity and specificity of direct immunofluorescence testing in disorders of mucous membranes. J Am Acad Dermatol (1994) 0.90
Recombinant desmoglein 3 has the necessary epitopes to adsorb and induce blister-causing antibodies. J Invest Dermatol (1996) 0.90
Subcutaneous morphoea: a clinical study of sixteen cases. Br J Dermatol (1979) 0.89
Complement fixation by pemphigus antibody. III. Altered epidermal cell membrane integrity mediated by pemphigus antibody and complement. J Invest Dermatol (1986) 0.89
Separation of epidermis from dermis with sodium thiocyanate. J Invest Dermatol (1977) 0.88
Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP). Transl Psychiatry (2013) 0.88
"An unusual type of pemphigus combining features of lupus erythematosus" by Senear and Usher, June 1926. Commentary: Pemphigus erythematosus, a unique member of the pemphigus group. Arch Dermatol (1982) 0.88
Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies. Proc Soc Exp Biol Med (1976) 0.87
Complement fixation by pemphigus antibody. I. In vitro fixation to organ and tissue culture skin. J Invest Dermatol (1984) 0.87
Chronic urticaria-like lesions in systemic lupus erythematosus. A review of 12 cases. Arch Dermatol (1978) 0.87
Clinical assessment and outcome in 70 patients with complaints of burning or sore mouth symptoms. Mayo Clin Proc (1999) 0.87
Bullous pemphigoid responding to sulfapyridine and the sulfones. Arch Dermatol (1977) 0.87
Evaluation of ammonium lactate in the treatment of seborrheic keratoses. J Am Acad Dermatol (1990) 0.86
Pemphigus immunoglobulin G subclass autoantibodies: studies of reactivity with cultured human keratinocytes. J Lab Clin Med (1990) 0.86
Oesophageal involvement in bullous pemphigoid. A possible cause of gastrointestinal haemorrhage. Br J Dermatol (1978) 0.86
Cigarette smoking and oral lesions other than cancer. Clin Dermatol (1998) 0.86
Behçet's disease. J Am Acad Dermatol (1990) 0.86
The complement system in pemphigus, bullous pemphigoid and herpes gestationis. Int J Dermatol (1979) 0.86
Clinical variants of pemphigoid. Int J Dermatol (1986) 0.85
Dermal-epidermal deposition of complement components and properdin in systemic lupus erythematosus. Br J Dermatol (1975) 0.85
Pemphigus-like antibodies in bullous pemphigoid. Arch Dermatol (1977) 0.85
Herpes Zoster in the elderly. Postgrad Med (1971) 0.85
Lichen planus and cicatricial conjunctivitis: disease course and response to therapy of 11 patients. J Eur Acad Dermatol Venereol (2011) 0.84
Incontinentia pigmenti: a failure of immune tolerance? J Am Acad Dermatol (1985) 0.84
Unilateral nevoid telangiectasia. Arch Dermatol (1979) 0.84